Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: We analyzed the prescriptions of alpha-blockers and phosphodiesterase 5 inhibitors (PDE5Is) in the urology department as well as in other departments of the general hospital. Methods: We investigated the frequency of prescription of alpha-blockers and PDE5Is from 3 general hospitals from January 1, 2007 to December 31, 2009. For alpha-blockers, data were collected from patients to whom alpha-blockers were prescribed from among patients recorded as having benign prostatic hyperplasia according to the 5th Korean Standard Classification of Diseases. For PDE5Is, data were collected from patients to whom PDE5Is were prescribed by the urology department and by other departments. Alpha-blockers were classified into tamsulosin, alfuzosin, doxazosin, and terazosin, whereas PDE5Is were classified into sildenafil, tadalafil, vardenafil, udenafil, and mirodenafil. Results: Alpha-blockers were prescribed to 11,436 patients in total over 3 years, and the total frequency of prescriptions was 68,565. Among other departments, the nephrology department had the highest frequency of prescription of 3,225 (4.7%), followed by the cardiology (3,101, 4.5%), neurology (2,576, 3.8%), endocrinology (2,400, 3.5%), pulmonology (1,102, 1.6%), and family medicine (915, 1.3%) departments in order. PDE5Is were prescribed to 2,854 patients in total over 3 years, and the total frequency of prescriptions was 10,558. The prescription frequency from the urology department was 4,900 (46.4%). Among other departments, the endocrinology department showed the highest prescription frequency of 3,488 (33.0%), followed by the neurology (542, 5.1%), cardiology (467, 4.4%), and family medicine (407, 3.9%) departments in order. Conclusions: A high percentage of prescriptions of alpha-blockers and PDE5Is were from other departments. For more specialized medical care by urologists is required in the treatment of lower urinary tract symptoms and erectile dysfunction.
Abstract
Purpose: We analyzed the prescriptions of alpha-blockers and phosphodiesterase 5 inhibitors (PDE5Is) in the urology department as well as in other departments of the general hospital. Methods: We investigated the frequency of prescription of alpha-blockers and PDE5Is from 3 general hospitals from January 1, 2007 to December 31, 2009. For alpha-blockers, data were collected from patients to whom alpha-blockers were prescribed from among patients recorded as having benign prostatic hyperplasia according to the 5th Korean Standard Classification of Diseases. For PDE5Is, data were collected from patients to whom PDE5Is were prescribed by the urology department and by other departments. Alpha-blockers were classified into tamsulosin, alfuzosin, doxazosin, and terazosin, whereas PDE5Is were classified into sildenafil, tadalafil, vardenafil, udenafil, and mirodenafil. Results: Alpha-blockers were prescribed to 11,436 patients in total over 3 years, and the total frequency of prescriptions was 68,565. Among other departments, the nephrology department had the highest frequency of prescription of 3,225 (4.7%), followed by the cardiology (3,101, 4.5%), neurology (2,576, 3.8%), endocrinology (2,400, 3.5%), pulmonology (1,102, 1.6%), and family medicine (915, 1.3%) departments in order. PDE5Is were prescribed to 2,854 patients in total over 3 years, and the total frequency of prescriptions was 10,558. The prescription frequency from the urology department was 4,900 (46.4%). Among other departments, the endocrinology department showed the highest prescription frequency of 3,488 (33.0%), followed by the neurology (542, 5.1%), cardiology (467, 4.4%), and family medicine (407, 3.9%) departments in order. Conclusions: A high percentage of prescriptions of alpha-blockers and PDE5Is were from other departments. For more specialized medical care by urologists is required in the treatment of lower urinary tract symptoms and erectile dysfunction.
참고문헌 (19)
- Wang C, "Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia", Curr Opin Urol, 20, pp.49~54 (2010)
- Madersbacher S, "EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines)", Eur Urol, 46, pp.547~554 (2004)
- Wespes E, "EAU Guidelines on erectile dysfunction: an update", Eur Urol, 49, pp.806~815 (2006)
- Porru D, "Prognostic value of a combination of IPSS, flow rate and residual urine volume compared to pressure-flow studies in the preoperative evaluation of symptomatic BPH", Eur Urol, 41, pp.246~249 (2002)
- Rosen RC, "Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction", Int J Impot Res, 11, pp.319~326 (1999)
- Brown MT, "Medication adherence: WHO cares", Mayo Clin Proc, 86, pp.304~314 (2011)
- Osterberg L, "Adherence to medication", N Engl J Med, 353, pp.487~497 (2005)
- Black HR, "Will better-tolerated antihypertensive agents improve blood pressure control? JNC VI revisited", Am J Hypertens, 12(12 Pt 3), pp.225S~230S (1999)
- Elliott WJ, "Hypertension in patients with diabetes. Overcoming barriers to effective control", Postgrad Med, 107, pp.29~38 (2000)
- Golin CE, "A prospective study of predictors of adherence to combination antiretroviral medication", J Gen Intern Med, 17, pp.756~765 (2002)
- Zolnierek KB, "Physician communication and patient adherence to treatment: a meta-analysis", Med Care, 47, pp.826~834 (2009)
- Collins MM, "Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians", J Gen Intern Med, 12, pp.224~229 (1997)
- Seftel AD, "Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty", Int J Clin Pract, 62, pp.614~622 (2008)
- 오철용, "Korean Urologist’s View of Practice Patterns in Diagnosis and Management of Benign Prostatic Hyperplasia: A Nationwide Survey", Yonsei Medical Journal, 51(2), pp.248~252 (2010), 연세대학교의과대학
- Rutchik SD, "Practice patterns in the diagnosis and treatment of erectile dysfunction among family practice physicians", Urology, 57, pp.146~150 (2001)
- Young SE, "Practice patterns in sildenafil prescribing", Fam Med, 38, pp.110~115 (2006)
- Hatzimouratidis K, "Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation", Eur Urol, 57, pp.804~814 (2010)
- Chung TG, "The Korean Version of the International Index of Erectile Function (IIEF) : Reliability and Validation Study", Korean J Urol, 40, pp.1334~1343 (1999)
- Ahn TY, "Validation of an abridged Korean Version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction", Korean J Urol, 42, pp.535~540 (2001)